Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hertle

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
BJU International|February 7, 2004
Unilateral multicystic dysplastic kidney: experience in childrenE Kuwertz-Broeking, O A Brinkmann, H J Von Lengerke, et al.
Cancer Research|February 24, 2001
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cellsR Simon, E Eltze, K L Schäfer, et al.
Clinical Chemistry|July 27, 2001
Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?A Semjonow, F Oberpenning, C Weining, et al.
Urologia Internationalis|April 24, 2001
The Ageing Male. A consensus statement from the joint multidisciplinary working group of the German Society of Andrology, the German Society of Dermatology, the German Society of Endocrinology and the German Society of UrologyW Weidner, H Behre, M Beutel, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|July 5, 2005
[Fetal nephro-/uropathy: a retrospective analysis of 124 cases seen in the period from 1996 to 2002]M Bulla, E Kuwertz-Bröking, S Fründ, et al.
Bone Marrow Transplantation|February 14, 2012
High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 casesM Mohr, I Hartig, T Kessler, et al.
Purinergic Signalling|July 20, 2021
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profileJ Merz, A Nettesheim, S von Garlen, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Der Urologe. Ausg. A|April 6, 2012
[Secondary malignancies in urinary diversions]T Kälble, I Hofmann, J W Thüroff, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
BJU International|February 7, 2004
Unilateral multicystic dysplastic kidney: experience in childrenE Kuwertz-Broeking, O A Brinkmann, H J Von Lengerke, et al.
Cancer Research|February 24, 2001
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cellsR Simon, E Eltze, K L Schäfer, et al.
Clinical Chemistry|July 27, 2001
Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?A Semjonow, F Oberpenning, C Weining, et al.
Urologia Internationalis|April 24, 2001
The Ageing Male. A consensus statement from the joint multidisciplinary working group of the German Society of Andrology, the German Society of Dermatology, the German Society of Endocrinology and the German Society of UrologyW Weidner, H Behre, M Beutel, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|July 5, 2005
[Fetal nephro-/uropathy: a retrospective analysis of 124 cases seen in the period from 1996 to 2002]M Bulla, E Kuwertz-Bröking, S Fründ, et al.
Bone Marrow Transplantation|February 14, 2012
High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 casesM Mohr, I Hartig, T Kessler, et al.
Purinergic Signalling|July 20, 2021
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profileJ Merz, A Nettesheim, S von Garlen, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Der Urologe. Ausg. A|April 6, 2012
[Secondary malignancies in urinary diversions]T Kälble, I Hofmann, J W Thüroff, et al.
Pageof 12